Impact of tolvaptan on improvement of tricuspid regurgitation and right ventricular dimension in patients with right-sided heart failure

[1]  Timothy M. Markman,et al.  Improvement in tricuspid regurgitation following catheter ablation of atrial fibrillation , 2020, Journal of cardiovascular electrophysiology.

[2]  B. Prendergast,et al.  Mitral regurgitation in heart failure: time for a rethink. , 2019, European heart journal.

[3]  V. Nkomo,et al.  Characteristics and treatment strategies for severe tricuspid regurgitation , 2019, Heart.

[4]  A. Sannino,et al.  Proportionate and Disproportionate Functional Mitral Regurgitation: A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials. , 2019, JACC. Cardiovascular imaging.

[5]  T. Imamura,et al.  Update of acute and long-term tolvaptan therapy. , 2019, Journal of cardiology.

[6]  P. Voisine,et al.  Transcatheter Mitral-Valve Repair in Patients with Heart Failure. , 2019, The New England journal of medicine.

[7]  T. Muramatsu,et al.  A novel validated method for predicting the risk of re-hospitalization for worsening heart failure and the effectiveness of the diuretic upgrading therapy with tolvaptan , 2018, PloS one.

[8]  Y. Kawai,et al.  Right ventricular enlargement predicts responsiveness to tolvaptan in congestive heart failure patients with reduced ejection fraction , 2018, International journal of cardiology. Heart & vasculature.

[9]  Li Jiang,et al.  Short-Term Effects of Tolvaptan in Tricuspid Insufficiency Combined with Left Heart Valve Replacement-Caused Volume-Overload Patients: Results of a Prospective Pilot Study , 2018, American Journal of Cardiovascular Drugs.

[10]  D. Maucort-Boulch,et al.  Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation , 2018, The New England journal of medicine.

[11]  J. Navia,et al.  Transcatheter Tricuspid Valve Interventions: Landscape, Challenges, and Future Directions. , 2018, Journal of the American College of Cardiology.

[12]  H. Takashima,et al.  Impact of Continuous Administration of Tolvaptan on Preventing Medium-Term Worsening Renal Function and Long-Term Adverse Events in Heart Failure Patients with Chronic Kidney Disease. , 2018, International heart journal.

[13]  K. Kinugawa,et al.  Tolvaptan Improves Prognosis in Responders with Acute Decompensated Heart Failure by Reducing the Dose of Loop Diuretics. , 2018, International heart journal.

[14]  V. Miller,et al.  National Trends and Outcomes in Isolated Tricuspid Valve Surgery. , 2017, Journal of the American College of Cardiology.

[15]  T. Murohara,et al.  Safety and Efficacy of Long-Term Use of Tolvaptan in Patients With Heart Failure and Chronic Kidney Disease. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[16]  Yuchi Han,et al.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  R. Siegel,et al.  Functional Tricuspid Regurgitation Caused by Chronic Atrial Fibrillation: A Real-Time 3-Dimensional Transesophageal Echocardiography Study. , 2017, Circulation. Cardiovascular imaging.

[18]  M. Endo,et al.  Tricuspid surgery for tricuspid regurgitation: review , 2016, General Thoracic and Cardiovascular Surgery.

[19]  K. Sugi,et al.  Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction. , 2016, Journal of cardiac failure.

[20]  J. Piccini,et al.  Atrial fibrillation in heart failure: what should we do? , 2015, European heart journal.

[21]  M. Tsutsumi,et al.  Efficacy And Safety of Coadministration of Tolvaptan And Carperitide for Acute Decompensated Heart Failure Patients , 2015 .

[22]  M. Humbert,et al.  Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension , 2015, European Respiratory Journal.

[23]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[24]  Y. Shibagaki,et al.  Efficacy of Tolvaptan Added to Furosemide in Heart Failure Patients with Advanced Kidney Dysfunction: A Pharmacokinetic and Pharmacodynamic Study , 2015, Clinical Pharmacokinetics.

[25]  M. O'Neill,et al.  Catheter ablation of atrial fibrillation in heart failure. , 2013, Heart failure clinics.

[26]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[27]  M. Keane,et al.  Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. , 2011, Journal of the American College of Cardiology.

[28]  J. Brugada,et al.  Long-term effect of cardiac resynchronization therapy on functional mitral valve regurgitation. , 2009, The American journal of cardiology.

[29]  G. Fonarow,et al.  Relation of loop diuretic dose to mortality in advanced heart failure. , 2006, The American journal of cardiology.

[30]  J. Ouyang,et al.  Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. , 2006, American journal of physiology. Renal physiology.

[31]  John Gorcsan,et al.  Echocardiography and Resynchronization A Mechanism for Immediate Reduction in Mitral Regurgitation After Cardiac Resynchronization Therapy Insights From Mechanical Activation Strain Mapping , 2004 .

[32]  Jayant Nath,et al.  Impact of tricuspid regurgitation on long-term survival. , 2004, Journal of the American College of Cardiology.

[33]  J. Almeida Intermediate-term outcome of mitral reconstruction in cardiomyopathy. , 1999, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.